Presentation on transcranial magnetic stimulation and ketamine
Educational Activities (EA)
60.0
Reviewing Performance (RP)
Measuring Outcomes (MO)
Brief Overview
This educational session provides general practitioners with an overview of emerging, evidence-based treatments for treatment-resistant depression and related mood disorders, focusing on Transcranial Magnetic Stimulation (TMS) and Ketamine therapy.
Participants will gain insight into the mechanisms of action, clinical indications, and referral criteria for these advanced psychiatric treatments. The presentation will also address patient selection, safety considerations, and the GP’s role in identifying suitable candidates, monitoring outcomes, and coordinating care with psychiatry specialists.
The session aims to build awareness and confidence in discussing these novel interventions with patients while reinforcing the importance of multidisciplinary, evidence-based mental health management.
Program Details
By completing this activity, participants will be able to:
- Expand knowledge of emerging psychiatric treatments, including Transcranial Magnetic Stimulation (TMS) and Ketamine therapy, and their roles in managing treatment-resistant depression.
- Develop clinical skills to identify suitable patients for these advanced interventions and understand the referral and monitoring process.
- Enhance communication skills to confidently discuss novel treatment options and expectations with patients and families.
- Adopt a collaborative attitude by strengthening partnerships between GPs, psychiatrists, and mental health services for integrated care.
- Promote evidence-based practice by staying informed about innovative, safe, and effective mental health treatments available to patients.
Program Outcome
Education on transcranial magnetic stimulation and ketamine treatment
- To learn about transcranial magnetic stimulation (TMS) and ketamine treatment
- Indications, including treatment resistant depression, anxiety, OCD, and PTSD
- Superior evidence compared to medications
- Logistics (2 days off per week for ketamine, TMS requires up to 35 sessions of 20 minutes per time)
- Costs (TMS is fully bulk-billed, ketamine is affordable for DVA, workcover, and those on the extended safety net)
Presentation and Q&A
Feedback to refine activity
Core Medical Practice Values
Provides those with stigma against medications alternatives to their treatments
To learn about and able to offer the best treatment options available
Topics Covered
Addiction Medicine
---
Anaesthetics
---
Blog Category
---
Cardiology and Vascular
---
Dentistry
---
Dermatology
---
Diagnostics and Pathology
---
Ear Nose and Throat (ENT)
---
Endocrinology
---
Events
---
FAQs Section
---
Gastroenterology and Hepatology
---
General Surgery
---
Genetic
---
Geriatrician
---
Gynaecology and Obstetric
---
Haematology
---
Immunology and Allergy
---
Master
---
Nephrology
---
Neurology and Neurosurgery
---
Oncology
---
Ophthalmology
---
Orthopedics
---
Paediatric
---
Plastic and Cosmetic Surgery
---
Program Category
---
Program Type
---
Psychiatry
---
Radiology
---
Rehabilitation Medicine
---
Respiratory
---
Rheumatology
---
Sexual and Reproductive Health
---
Urological Services
---
Topic
---
Delivery Method & Format
0 Hours total Duration
In Person
Knowledge Sharing: Conference, Lecture (emphasises presenting information and fostering discussion)
CPD Home (Accreditor)
Suited for
Practitioners
AUS
can